Related Experiment Video
Updated: Jun 5, 2026

10:52
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
Published on: March 30, 2018
Oesophageal involvement in mantle cell lymphoma
1Department of Medicine, Medical College, 88 College Street, Kolkata 700073, West Bengal, India. g.santra@yahoo.com
Singapore Medical Journal
|January 12, 2011
Summary
Oesophageal lymphomas are rare, especially in mantle cell lymphoma (MCL). This case highlights secondary MCL involvement causing multiple polyposis in the oesophagus and intestines.
Area of Science:
- Gastroenterology
- Oncology
- Pathology
Background:
- Mantle cell lymphoma (MCL) commonly affects the gastrointestinal tract, but oesophageal involvement is rare.
- Multiple lymphomatous polyposis (MLP) is an intestinal manifestation of MCL, typically seen in elderly patients.
- Tumor cells in MCL usually express CD5 and cyclin D1 markers.
Observation:
- The patient presented with generalized lymphadenopathy, dysphagia, and significant weight loss.
- Upper gastrointestinal endoscopy identified submucosal polypoid lesions in the oesophagus, stomach, and duodenum.
- Histopathology and immunophenotyping confirmed mantle cell lymphoma.
Findings:
- The patient had secondary involvement from systemic MCL, leading to multiple intestinal polyposis.
- This included oesophageal polyposis, an uncommon presentation of MCL.
- The findings expand the understanding of MLP in the context of systemic MCL.
Implications:
- This case underscores the importance of considering secondary MCL involvement in the upper gastrointestinal tract, including the oesophagus.
- It highlights the diagnostic challenges and rare presentations of mantle cell lymphoma.
- Further research into the mechanisms and management of oesophageal MLP in systemic MCL is warranted.
Related Concept Videos
Barrett Esophagus-II: Clinical Manifestations and Management
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Esophageal Achalasia
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
Barrett Esophagus-I: Introduction
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Esophagus
The esophagus, a muscular conduit linking the pharynx and stomach, measures roughly 10 inches (25.4 cm) and sits behind the trachea. It remains collapsed when not swallowing. The esophagus follows a predominantly straight path through the thoracic mediastinum and enters the abdominal cavity through a diaphragmatic opening known as the esophageal hiatus.
The movement of edibles from the pharynx into the esophagus is facilitated by the upper esophageal sphincter, which is formed primarily by the...
The movement of edibles from the pharynx into the esophagus is facilitated by the upper esophageal sphincter, which is formed primarily by the...
Esophageal Strictures-I: Introduction
Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Esophageal Perforation-II: Clinical Manifestations and Management
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Clinical Manifestations:
